A6
Term · Oncology and biomedicine · MLC-T-ONC-000087
A substance being studied in the treatment of cancer. A6 is a small piece of a protein called urokinase (an enzyme that dissolves blood clots or prevents them from forming). It is a type of antiangiogenesis agent and a type of antimetastatic agent. Also called urokinase plasminogen activator (uPA)-derived peptide A6.
| Identifier | MLC-T-ONC-000087 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | urokinase plasminogen activator (uPA)-derived peptide A6 |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-000087",
"term": "A6",
"field": "Oncology and biomedicine",
"definition": "A substance being studied in the treatment of cancer. A6 is a small piece of a protein called urokinase (an enzyme that dissolves blood clots or prevents them from forming). It is a type of antiangiogenesis agent and a type of antimetastatic agent. Also called urokinase plasminogen activator (uPA)-derived peptide A6.",
"synonyms": [
"urokinase plasminogen activator (uPA)-derived peptide A6"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/a6/"
}
Record 145 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.